SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Anavex Life Sciences Corp. – ‘10-K’ for 9/30/20 – ‘EXCEL’

On:  Monday, 12/28/20, at 5:27pm ET   ·   For:  9/30/20   ·   Accession #:  1731122-20-1338   ·   File #:  1-37606

Previous ‘10-K’:  ‘10-K’ on 12/16/19 for 9/30/19   ·   Next:  ‘10-K’ on 11/24/21 for 9/30/21   ·   Latest:  ‘10-K’ on 11/27/23 for 9/30/23   ·   15 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/28/20  Anavex Life Sciences Corp.        10-K        9/30/20   44:3.6M                                   Electro Filings LLC/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    794K 
 2: EX-21.1     Subsidiaries List                                   HTML     13K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML     13K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     18K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     18K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     14K 
13: R1          Cover                                               HTML     77K 
14: R2          Consolidated Balance Sheets                         HTML     55K 
15: R3          Consolidated Balance Sheets (Parenthetical)         HTML     26K 
16: R4          Consolidated Statements of Operations               HTML     61K 
17: R5          Consolidated Statements of Cash Flows               HTML     58K 
18: R6          Consolidated Statement of Changes in Stockholders'  HTML     60K 
                Equity                                                           
19: R7          Business Description and Basis of Presentation      HTML     25K 
20: R8          Summary of Significant Accounting Policies          HTML     57K 
21: R9          Other Income                                        HTML     22K 
22: R10         Equity Offering Agreements                          HTML     39K 
23: R11         Commitments                                         HTML     84K 
24: R12         Income Taxes                                        HTML     44K 
25: R13         Summary of Significant Accounting Policies          HTML     94K 
                (Policies)                                                       
26: R14         Commitments (Tables)                                HTML     74K 
27: R15         Income Taxes (Tables)                               HTML     37K 
28: R16         Summary of Significant Accounting Policies          HTML     18K 
                (Details Narrative)                                              
29: R17         Other Income (Details Narrative)                    HTML     26K 
30: R18         Equity Offering Agreements (Details Narrative)      HTML     55K 
31: R19         Commitments (Details)                               HTML     33K 
32: R20         Commitments (Details 1)                             HTML     26K 
33: R21         Commitments (Details 2)                             HTML     47K 
34: R22         Commitments (Details 3)                             HTML     21K 
35: R23         Commitments (Details 4)                             HTML     23K 
36: R24         Commitments (Details Narrative)                     HTML     38K 
37: R25         Income Taxes (Details)                              HTML     22K 
38: R26         Income Taxes (Details 1)                            HTML     31K 
39: R27         Income Taxes (Details 2)                            HTML     37K 
40: R28         Income Taxes (Details Narrative)                    HTML     26K 
42: XML         IDEA XML File -- Filing Summary                      XML     69K 
12: XML         XBRL Instance -- e2298_10k_htm                       XML    537K 
41: EXCEL       IDEA Workbook of Financial Reports                  XLSX     53K 
 8: EX-101.CAL  XBRL Calculations -- avxl-20200930_cal               XML     77K 
 9: EX-101.DEF  XBRL Definitions -- avxl-20200930_def                XML    200K 
10: EX-101.LAB  XBRL Labels -- avxl-20200930_lab                     XML    561K 
11: EX-101.PRE  XBRL Presentations -- avxl-20200930_pre              XML    398K 
 7: EX-101.SCH  XBRL Schema -- avxl-20200930                         XSD     85K 
43: JSON        XBRL Instance as JSON Data -- MetaLinks              181±   247K 
44: ZIP         XBRL Zipped Folder -- 0001731122-20-001338-xbrl      Zip    253K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/21  Anavex Life Sciences Corp.        424B5                  1:299K                                   Electro Filings LLC/FA


14 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/02/20  Anavex Life Sciences Corp.        8-K:1,9     7/01/20    3:46K                                    Electro Filings LLC/FA
 5/01/20  Anavex Life Sciences Corp.        8-K:1,8,9   5/01/20    4:290K                                   Electro Filings LLC/FA
 2/06/20  Anavex Life Sciences Corp.        10-Q       12/31/19   36:1.9M                                   Electro Filings LLC/FA
 6/12/19  Anavex Life Sciences Corp.        8-K:1,9     6/07/19    4:372K                                   EdgarAgents LLC/FA
 5/09/19  Anavex Life Sciences Corp.        10-Q        3/31/19   38:3.3M                                   S2 Filings LLC/FA
 2/11/19  Anavex Life Sciences Corp.        DEF 14A     4/05/19    1:1.6M                                   S2 Filings LLC/FA
12/11/17  Anavex Life Sciences Corp.        10-K        9/30/17   51:4M                                     S2 Filings LLC/FA
12/14/16  Anavex Life Sciences Corp.        10-K        9/30/16   62:4.4M                                   S2 Filings LLC/FA
 7/22/16  Anavex Life Sciences Corp.        8-K:5,9     7/18/16    2:130K                                   S2 Filings LLC/FA
 7/07/16  Anavex Life Sciences Corp.        8-K:5,9     7/05/16    2:130K                                   S2 Filings LLC/FA
12/29/15  Anavex Life Sciences Corp.        10-K        9/30/15   73:5M                                     S2 Filings LLC/FA
 9/28/07  Anavex Life Sciences Corp.        8-K:5,9     4/17/07    4:230K                                   Clark Wilson/FA
 1/25/07  Anavex Life Sciences Corp.        8-K:5,7,9   1/25/07    3:811K                                   Clark Wilson/FA
 1/13/05  Anavex Life Sciences Corp.        SB-21/12/05    9:5.8M                                   Fraser & Co. Inc./FA
Top
Filing Submission 0001731122-20-001338   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 7:44:36.3pm ET